What question did this study set out to answer?

To measure the seroprevalence of SARS-CoV-2 antibodies in Conakry and identify associated factors after the public health emergency.

August 10, 2026BMC Public HealthOpen Access

Post-pandemic SARS-CoV-2 seroprevalence and population immunity in Conakry, Guinea, 2024

View Full Paper

Ask AI

Bookmark

To measure the seroprevalence of SARS-CoV-2 antibodies in Conakry and identify associated factors after the public health emergency.
Population-based survey conducted in January 2024 with demographic and epidemiological data collection.
Age-stratified sampling from 1018 individuals across 180 households.
Testing for IgG antibodies to SARS-CoV-2 using Luminex technology.
Weighted and age-standardized seroprevalence of SARS-CoV-2 IgG antibodies was 88.9% (95% CI: 80.8–93.9).
Individuals with secondary education showed increased odds of antibody positivity (AOR = 4.10, 95% CI: 1.46–11.51).
Vaccinated individuals had a higher likelihood of having antibodies (AOR = 2.53, 95% CI: 1.26–5.10).

No takes yet. Share an insight, caveat, or question.

Population-based survey measures high SARS-CoV-2 seroprevalence in Conakry, indicating significant community exposure.

Kadio et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark